Literature DB >> 18560993

Predicting breast cancer risk: implications of a "weak" family history.

Elaine Anderson1, Jonathan Berg, Roger Black, Nicola Bradshaw, Joyce Campbell, Roseanne Cetnarskyj, Sarah Drummond, Rosemarie Davidson, Jacqueline Dunlop, Alison Fordyce, Barbara Gibbons, David Goudie, Helen Gregory, Kirstie Hanning, Susan Holloway, Mark Longmuir, Lorna McLeish, Vicky Murday, Zosia Miedzybrodska, Donna Nicholson, Pauline Pearson, Mary Porteous, Marta Reis, Sheila Slater, Karen Smith, Elizabeth Smyth, Lesley Snadden, Michael Steel, Diane Stirling, Cathy Watt, Catriona Whyte, Dorothy Young.   

Abstract

Published guidelines adopted in many countries recommend that women whose family history of breast cancer places them at a risk>or=1.7 times that of the age-matched general population, should be considered for inclusion in special surveillance programmes. However validation of risk assessment models has been called for as a matter of urgency. The databases of the four Scottish Familial Breast Cancer clinics and the Scottish Cancer Registry have been searched to identify breast cancers occurring among 1,125 women aged 40-56, with family histories placing them below the "moderate" level of genetic risk. The observed incidence over 6 years was compared with age-specific data for the Scottish population. Our findings confirm that when there are two affected relatives (one first degree) the relative risk (RR) exceeds 1.7 regardless of their ages at diagnosis. When only one (first degree) relative was affected at any age from 40 to 55, the RR does not reach 1.7 if that relative was a mother but exceeds it if the relative was a sister. The probable explanation is that sisters are more likely than mother/daughter pairs to share homozygosity for a risk allele. Surveillance programmes might therefore accommodate sisters of women affected before age 55. Evidence that "low penetrance" alleles contributing to breast cancer risk may be recessive should be taken into account in strategies for identifying them.

Entities:  

Mesh:

Year:  2008        PMID: 18560993     DOI: 10.1007/s10689-008-9197-5

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  16 in total

1.  Familial predisposition to breast cancer in a British population: implications for prevention.

Authors:  P D Pharoah; J M Lipscombe; K L Redman; N E Day; D F Easton; B A Ponder
Journal:  Eur J Cancer       Date:  2000-04       Impact factor: 9.162

2.  Analysis of referrals to a multi-disciplinary breast cancer genetics clinic: practical and economic considerations.

Authors:  Marta M Reis; Dorothy Young; Lorna McLeish; David Goudie; Alan Cook; Frank Sullivan; Helen Vysny; Alison Fordyce; Roger Black; Manouche Tavakoli; Michael Steel
Journal:  Fam Cancer       Date:  2006-07-01       Impact factor: 2.375

Review 3.  Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force.

Authors:  Heidi D Nelson; Laurie Hoyt Huffman; Rongwei Fu; Emily L Harris
Journal:  Ann Intern Med       Date:  2005-09-06       Impact factor: 25.391

Review 4.  Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease.

Authors: 
Journal:  Lancet       Date:  2001-10-27       Impact factor: 79.321

5.  Family history, age, and risk of breast cancer. Prospective data from the Nurses' Health Study.

Authors:  G A Colditz; W C Willett; D J Hunter; M J Stampfer; J E Manson; C H Hennekens; B A Rosner
Journal:  JAMA       Date:  1993-07-21       Impact factor: 56.272

6.  Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme.

Authors:  E Amir; D G Evans; A Shenton; F Lalloo; A Moran; C Boggis; M Wilson; A Howell
Journal:  J Med Genet       Date:  2003-11       Impact factor: 6.318

7.  The Teesside cancer family history service: change management and innovation at cancer network level.

Authors:  Paul Brennan; Oonagh Claber; Tracey Shaw
Journal:  Fam Cancer       Date:  2007-05-17       Impact factor: 2.375

8.  Genome-wide association study identifies novel breast cancer susceptibility loci.

Authors:  Douglas F Easton; Karen A Pooley; Alison M Dunning; Paul D P Pharoah; Deborah Thompson; Dennis G Ballinger; Jeffery P Struewing; Jonathan Morrison; Helen Field; Robert Luben; Nicholas Wareham; Shahana Ahmed; Catherine S Healey; Richard Bowman; Kerstin B Meyer; Christopher A Haiman; Laurence K Kolonel; Brian E Henderson; Loic Le Marchand; Paul Brennan; Suleeporn Sangrajrang; Valerie Gaborieau; Fabrice Odefrey; Chen-Yang Shen; Pei-Ei Wu; Hui-Chun Wang; Diana Eccles; D Gareth Evans; Julian Peto; Olivia Fletcher; Nichola Johnson; Sheila Seal; Michael R Stratton; Nazneen Rahman; Georgia Chenevix-Trench; Stig E Bojesen; Børge G Nordestgaard; Christen K Axelsson; Montserrat Garcia-Closas; Louise Brinton; Stephen Chanock; Jolanta Lissowska; Beata Peplonska; Heli Nevanlinna; Rainer Fagerholm; Hannaleena Eerola; Daehee Kang; Keun-Young Yoo; Dong-Young Noh; Sei-Hyun Ahn; David J Hunter; Susan E Hankinson; David G Cox; Per Hall; Sara Wedren; Jianjun Liu; Yen-Ling Low; Natalia Bogdanova; Peter Schürmann; Thilo Dörk; Rob A E M Tollenaar; Catharina E Jacobi; Peter Devilee; Jan G M Klijn; Alice J Sigurdson; Michele M Doody; Bruce H Alexander; Jinghui Zhang; Angela Cox; Ian W Brock; Gordon MacPherson; Malcolm W R Reed; Fergus J Couch; Ellen L Goode; Janet E Olson; Hanne Meijers-Heijboer; Ans van den Ouweland; André Uitterlinden; Fernando Rivadeneira; Roger L Milne; Gloria Ribas; Anna Gonzalez-Neira; Javier Benitez; John L Hopper; Margaret McCredie; Melissa Southey; Graham G Giles; Chris Schroen; Christina Justenhoven; Hiltrud Brauch; Ute Hamann; Yon-Dschun Ko; Amanda B Spurdle; Jonathan Beesley; Xiaoqing Chen; Arto Mannermaa; Veli-Matti Kosma; Vesa Kataja; Jaana Hartikainen; Nicholas E Day; David R Cox; Bruce A J Ponder
Journal:  Nature       Date:  2007-06-28       Impact factor: 49.962

9.  Prospective surveillance of women with a family history of breast cancer: auditing the risk threshold.

Authors:  E Anderson; J Berg; R Black; N Bradshaw; J Campbell; H Carnaghan; R Cetnarkyj; S Drummond; R Davidson; J Dunlop; A Fordyce; B Gibbons; D Goudie; H Gregory; S Holloway; M Longmuir; L McLeish; V Murday; Z Miedzybrodska; D Nicholson; P Pearson; M Porteous; M Reis; S Slater; K Smith; E Smyth; L Snadden; M Steel; D Stirling; C Watt; C Whyte; D Young
Journal:  Br J Cancer       Date:  2008-02-19       Impact factor: 7.640

10.  Referrals of women with a family history of breast cancer from primary care to cancer genetics services in South East Scotland.

Authors:  H Campbell; S Holloway; R Cetnarskyj; E Anderson; R Rush; A Fry; D Gorman; M Steel; M Porteous
Journal:  Br J Cancer       Date:  2003-11-03       Impact factor: 7.640

View more
  2 in total

1.  Can a phenotype for recessive inheritance in breast cancer be defined?

Authors:  Carolina Ellberg; Göran Jönsson; Håkan Olsson
Journal:  Fam Cancer       Date:  2010-12       Impact factor: 2.375

2.  Evaluation of the Families SHARE workbook: an educational tool outlining disease risk and healthy guidelines to reduce risk of heart disease, diabetes, breast cancer and colorectal cancer.

Authors:  Laura M Koehly; Bronwyn A Morris; Kaley Skapinsky; Andrea Goergen; Amanda Ludden
Journal:  BMC Public Health       Date:  2015-11-13       Impact factor: 3.295

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.